Safety of AZD1222 COVID-19 vaccine and low Incidence of SARS-CoV-2 infection in Botswana following ChAdOx1(AZD1222) vaccination: A single-arm open-label interventional study - final study results.

IJID Reg · 2024 · PMC10714336 · PMID 38090729

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a trend towards significanceno p-value reported

We observed higher binding antibody responses among participants with prior COVID-19 exposure after 28 days from baseline and a trend towards significance up to day 70, and no differences thereafter.

also in 2,760 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.